Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Gene activated human glucocerebrosidase, velaglucerase alfa
(Vpriv, VPRIV)		1件: Velaglucerase alfa1件: Velaglucerase alfa (Vpriv, VPRIV) 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
2Velaglucerase alfa
(Vpriv, VPRIV)		1件: Velaglucerase alfa1件: Velaglucerase alfa (Vpriv, VPRIV) 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
3Vpriv1件: Velaglucerase alfa1件: Velaglucerase alfa (Vpriv, VPRIV) 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
4Vpriv - 400 U - polvere PER soluzione PER infusione - USO endovenoso - flaconcino(vetro) 1 flaconcino1件: Velaglucerase alfa1件: Velaglucerase alfa (Vpriv, VPRIV) 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬
5Vpriv 400 units powder FOR solution OF infusion1件: Velaglucerase alfa1件: Velaglucerase alfa (Vpriv, VPRIV) 💬 1件: GBA 💬 4件: Cornified envelope formation, Lysosome, Other glycan degradation, Sphingolipid metabolism 💬1件: 19 💬